Radiation oncology firm Sirtex Medical has debuted Siros, a delivery system for its yttrium-90 (Y-90) microspheres.
The system is designed to deliver the company's SIR-Spheres Y-90 resin microspheres to patients undergoing radioembolization therapy for liver cancer. It uses visually controlled administration to help physicians quickly and precisely deliver the microspheres, the company noted.
Siros also features a three-step setup, peel-and-place tubing set, and locking cover to secure the microspheres during delivery. It also utilized needleless D-Vials that suspend the SIR-Spheres into a vortex for more even distribution.